FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.
marketwatch.com
23.09.2026 14:39
5 views
Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancers.
Related stories
‘It doesn’t seem fair’: I’m retired and have plenty of money. Why can’t I qualify for a retail credit card?
finance.yahoo.com · 23.09
Fed's Michael Barr backs more rate hikes as PMI hits 5-year high
finance.yahoo.com · 23.09
Creatio commits $300m to scale financial AI
finance.yahoo.com · 23.09
Meta’s Muse Just Put Instacart’s Grocery Empire on Notice
finance.yahoo.com · 23.09
Should You Sell Your APLD Stock Now?
finance.yahoo.com · 23.09
Rachel Cruze flags critical retirement mistake people make in their 20s
finance.yahoo.com · 23.09